The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study
口服促性腺激素释放激素拮抗剂瑞卢戈利治疗妊娠22周前流产后残留妊娠组织(RPOC)的疗效:一项回顾性研究
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1543272
Sasatsu, Satoko; Ono, Yosuke; Miyashita, Dai; Yoshihara, Tatsuya; Tanaka, Kota; Owada, So; Makino, Kana; Nakagomi, Akiko; Ogi, Maki; Ogasawara, Eriko; Tagaya, Hikaru; Fukasawa, Hiroko; Okuda, Yasuhiko; Yoshino, Osamu